The recent surges in cases of measles, cyclosporiasis, West Nile virus and mpox leave little room for doubt: the US Secretary of Health bears clear political responsibility for the current situation, which has been shaped by a number of decisions, ranging from staff cuts to anti-vaccine stances

The persecution of the immunologist therefore concerns far more than just the assessment of the pandemic: it shows what fate awaits any institution tasked with setting reality against the demands of those in power, when those in government believe they no longer need to answer to anything other than their own majority

The work by Takehiro Tottori and Tetsuya J. Kobayashi seeks to establish when it becomes advantageous to retain some of the information received in the past. Memory as a benefit and as a cost

Under a new German law, statutory health insurance funds will no longer be able to reimburse homeopathy and anthroposophic medicine. From 2027, the ban will then be extended permanently to include any form of supplementary cover or supplementary insurance policy that provides for the funding of such treatments

The comments made by the Conference of Regions and Autonomous Provinces largely coincide with the criticisms levelled by ISPRA and the experts heard by the Chamber of Deputies. And the text appears for what it is: a mere slapdash exercise designed to scrape together a few more votes ahead of the general election

Bills on the professional recognition of practitioners of Japanese massage have been tabled in Parliament. The problem, however, is that the two bills incorporate a vitalistic conception of the human body, based on invisible balances, self-healing capacities and benefits enshrined in law. Thus, the legislation takes precedence over evidence 

Some draft bills aim to secure parliamentary recognition of the ‘therapeutic value’ of complementary therapies. However, leading scientific assessments have never found evidence of efficacy superior to that of a placebo: legislation can regulate the sale, use and funding of a product, but it cannot prove that it cures a disease

European governments would like to cut funding for the programme through which the EU allocates funds to scientific projects. This stance already indicates the value they place on research, but it also increases the likelihood that Europe will one day have to buy solutions elsewhere that it did not help to develop

The shareholders’ meeting resolved to wind up the company just nine months after an interview in which the new management described 2025 as the year of rebirth. And the most serious contradiction concerns research

Thanks to the amendment tabled by the FdI MP, a provision intended for a small number of professionals can be sold to the entire anti-vaccine movement as a collective rehabilitation. The amnesty promised to that audience does not exist, whilst the political advantage generated by the announcement does